In a regulatory filing, Inari Medical disclosed that its director William Hoffman sold 55K shares of common stock on January 17th in a total transaction size of $3.68M.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on NARI:
- Inari:1st patient enrolled in ‘clinical outcomes’ study of ClotTriever for DVT
- Inari Medical sees FY23 revenue $470M-$480M, consensus $450.75M
- Inari Medical sees FY22 revenue $382.7M-$383.7M, consensus $374.77M
- Inari Medical sees Q4 revenue $107M-$108M, consensus $99.12M
- Inari Medical to Present at the 41st Annual J.P. Morgan Healthcare Conference